EBUS/Spectrum Analysis

To evaluate the clinical benefit of spectrum analysis of endobronchial ultrasound images of lymph nodes during EBUS TBNA for lymph node staging in patients with lung cancer.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Lung Cancer Lung Diseases Lung Neoplasms Neoplasms Neoplasms by Site Respiratory Tract Diseases Respiratory Tract Neoplasms Thoracic Neoplasms

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University Health Network

Toronto, Ontario, M5G 2C4, Canada

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Ages 18 years or older
Patients with known or suspected lung cancer who require EBUS-TBNA for lymph node staging

Exclusion criteria

Patients who are deemed on clinical grounds not to be medically fit for a bronchoscopy
Inability to give informed consent
Patients who are pregnant

Treatment and study plan

Spectrum Image Analysis using a Linear Array Ultrasound Bronchoscope

Device

Primary outcomes

Lymph Node Staging

Time frame: Pathology report will be completed as soon as possible after the procedure. (Within one year)

The lymph node staging will be determined by the pathology report of the biopsy taken from the patients lymph node(s).

Sponsors and collaborators

Lead sponsor

University Health Network, Toronto

Other

Registry information

Official study title

Spectrum Image Analysis of Lymph Nodes During Endobronchial Ultrasound-Guided (EBUS) Transbronchial Needle Aspiration (TBNA) in Patients With Lung Cancer

Important dates

Study start: 2013
Primary completion: 2015
Study completion: 2016
First posted: Oct 30, 2013
Registry last updated: Feb 23, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Completed